Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2

BACKGROUND: The receptor binding domain (RBD) of spike protein S1 domain SARS-CoV-2 plays a key role in the interaction with ACE2, which leads to subsequent S2 domain mediated membrane fusion and incorporation of viral RNA into host cells. In this study we tend to repurpose already approved drugs as...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Mol Graph Model
Main Authors: Prajapat, Manisha, Shekhar, Nishant, Sarma, Phulen, Avti, Pramod, Singh, Sanjay, Kaur, Hardeep, Bhattacharyya, Anusuya, Kumar, Subodh, Sharma, Saurabh, Prakash, Ajay, Medhi, Bikash
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier Inc. 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7442136/
https://ncbi.nlm.nih.gov/pubmed/32866780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmgm.2020.107716
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares